Literature DB >> 9515261

[Tobacco smoking among pregnant women in an urban area in southern Brazil, 1982-93].

B L Horta1, C G Victora, F C Barros, I da S dos Santos, A M Menezes.   

Abstract

OBJECTIVE: A comparison between on the prevalence of smoking during pregnancy in 1982 and that in 1993 in Pelotas, Southern Brazil.
METHODOLOGY: Cross-sectional study. All hospital deliveries in 1982 and 1993--corresponding to over 99% of all births in those years--were studied. A total of 6,011 and 5,304 mothers were interviewed, respectively.
RESULTS: The prevalence of smoking during pregnancy showed a small decrease from 35.7% in 1982 to 33.5% in 1993 (p < 0.05). In the two years under study, family income and number of antenatal care visits were inversely associated with the prevalence of maternal smoking. The rate of stopping smoking during pregnancy was 20.6%.

Entities:  

Mesh:

Year:  1997        PMID: 9515261

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  4 in total

1.  Maternal smoking and the risk of early weaning: a meta-analysis.

Authors:  B L Horta; M S Kramer; R W Platt
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  Maternal smoking and child psychological problems: disentangling causal and noncausal effects.

Authors:  Marie-Jo Brion; Cesar Victora; Alicia Matijasevich; Bernardo Horta; Luciana Anselmi; Colin Steer; Ana Maria B Menezes; Debbie A Lawlor; George Davey Smith
Journal:  Pediatrics       Date:  2010-06-29       Impact factor: 7.124

3.  Preventing smoking during pregnancy: the importance of maternal knowledge of the health hazards and of the treatment options available.

Authors:  André Luís Bertani; Thais Garcia; Suzana Erico Tanni; Irma Godoy
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

4.  Maternal pre-pregnancy BMI, gestational weight gain and breastfeeding.

Authors:  H Castillo; I S Santos; A Matijasevich
Journal:  Eur J Clin Nutr       Date:  2016-01-27       Impact factor: 4.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.